Stay updated on HOPE-B: AMT-061 Clinical Trial
Sign up to get notified when there's something new on the HOPE-B: AMT-061 Clinical Trial page.
Latest updates to the HOPE-B: AMT-061 Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThis page shows only minor administrative updates, including an updated Last Update Posted timestamp and small UI tweaks. There are no changes to eligibility criteria, study design, locations, interventions, or outcome measures. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check32 days agoChange DetectedAdded an important operating-status notice and updated version to v3.2.0; removed reference to v3.1.0.SummaryDifference3%
- Check39 days agoChange DetectedStandardize disease name capitalization to “Hemophilia B” and update the revision to v3.1.0 to reflect a new page version.SummaryDifference0.1%
- Check54 days agoChange DetectedPage version updated from v3.0.1 to v3.0.2 and the 'Back to Top' link was removed. No substantive content changes were detected.SummaryDifference0.2%
- Check61 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.SummaryDifference0.2%
- Check68 days agoChange DetectedThe webpage has been updated to include new facility names and locations, as well as additional publications related to gene therapy for hemophilia B. Notably, the term 'Hemophilia B' has been retained, ensuring continuity in core content.SummaryDifference14%
Stay in the know with updates to HOPE-B: AMT-061 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HOPE-B: AMT-061 Clinical Trial page.